Postfusional regulation of cleft glutamate concentration during LTP at 'silent synapses'

Nature Neuroscience

Volumn 3, Issue 4, 2000, Pages 330-336

  Choi, Sukwoo ^a   Klingauf, Jürgen ^a,b   Tsien, Richard W ^a  

^a STANFORD UNIVERSITY   (United States)

^b MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; AMPA RECEPTOR; CYCLOTHIAZIDE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; LONG TERM POTENTIATION; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPSE VESICLE; VOLTAGE CLAMP;

2-AMINO-5-PHOSPHONOVALERATE; 6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ANIMALS; ANTIHYPERTENSIVE AGENTS; BENZOTHIADIAZINES; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; EXTRACELLULAR SPACE; GLUTAMIC ACID; LONG-TERM POTENTIATION; PATCH-CLAMP TECHNIQUES; PYRAMIDAL CELLS; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPSES;

EID: 0034068876     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/73895     Document Type: Article

References (26)

1. Grace, A. A., Bunney, B. S., Moore, H. & Todd, C. L. Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs. Trends Neurosci. 20, 31-37 (1997).
2. Hynes M. & Rosenthal A. Specification of dopaminergic and serotonergic neurons in the vertebrate CNS. Curr. Opin. Neurobiol. 9, 26-36 (1999).
3. Ye, W., Shimamura, K., Rubenstein, J. L., Hynes, M. A. & Rosenthal, A. FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell 93, 755-766 (1998).
4. Shamim, H. et al. Sequential roles for Fgf4, En1 and Fgf8 in specification and regionalisation of the midbrain. Development 126, 945-959 (1999).
5. Danielian, P. S. & McMahon, A. P. Engrailed-1 as a target of the Wnt-1 signaling pathway in vertebrate midbrain development. Nature 383, 332-334 (1996).
6. Wurst, W., Auerbach, A. B. & Joyner, A. L. Multiple developmental defects in Engrailed-1 mutant mice: an early mid-hindbrain deletion and patterning defects in forelimbs and sternum. Development 120, 2065-2075 (1994).
7. Hanks, M., Wurst, W., Anson-Cartwright, L., Auerbach, A. B. & Joyner, A. L. Rescue of the En-1 mutant phenotype by replacement of En-1 with En-2. Science 269, 679-682 (1995).
8. Favor, J. et al. The mouse Pax2(1Neu) mutation is identical to a human PAX2 mutation in a family with renal-coloboma syndrome and results in developmental defects of the brain, ear, eye, and kidney. Proc. Natl. Acad. Sci. USA 93, 13870-13875 (1996).
9. Urbanek, P., Fetka, I., Meisler, M. H. & Busslinger, M. Cooperation of Pax2 and Pax5 in midbrain and cerebellum development. Proc. Natl. Acad. Sci. USA 94, 5703-5708 (1997).
10. Hynes, M. et al. Induction of midbrain dopaminergic neurons by Sonic hedgehog. Neuron 15, 35-44 (1995).
11. Smidt, M. P. et al. A novel homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons. Proc. Natl. Acad. Sci. USA 94, 13305-13310 (1997).
12. Zetterstrom, R. H. et al. Dopamine neuron agenesis in Nurr1-deficient mice. Science 276, 248-250 (1997).
13. Saucedo-Cardenas, O. et al. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc. Natl. Acad. Sci. USA 95, 4013-4018 (1998).
14. Johnson, R. L. & Tabin, C. L. Molecular models for vertebrate limb development. Cell 90, 979-990 (1997).
15. Dreyer, S. D. et al. Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome. Nat. Genet. 19, 47-50 (1998).
16. Chen, H. et al. Multiple calvarial defects in Lmx1b mutant mice. Dev. Genet. 22, 314-320 (1998).
17. Chen, H. et al. Limb and kidney defects in Lmx1b mutant mice suggest an involvement of LMX1B in human nail patella syndrome. Nat. Genet. 19, 51-55 (1998).
18. Tucker, A. S. et al. Conserved regulation of mesenchymal gene expression by Fgf-8 in face and limb development. Development 126, 221-228 (1999).
19. Tsuchida, T. et al. Topographic organization of embryonic motor neurons defined by expression of LIM homeobox genes. Cell 79, 957-970 (1994).
20. Thor, S., Andersson, S. G., Tomlinson, A. & Thomas, J. B. A LIM-homeodomain combinatorial code for motor-neuron pathway selection. Nature 397, 76-80 (1999).
21. Sharma, K. et al. LIM homeodomain factors Lhx3 and Lhx4 assign subtype identities for motor neurons. Cell 95, 817-828 (1998).
22. Arber, S. et al. Requirement for the homeobox gene Hb9 in the consolidation of motor neuron identity. Neuron 23, 659-674.
23. Perlow, M. J. Brain grafting as a treatment for Parkinson's disease. Neurosurgery 20, 335-342 (1987).
24. Date, I. et al. Preliminary report of polymer-encapsulated dopamine-secreting cell grafting into the brain. Cell Transplant. 5, S17-S19 (1996).
25. Kordower, J. H. et al. Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. J. Comp. Neurol. 370, 203-230 (1996).
26. Grima, B., Lamouroux, A., Blanot, F., Biguet, N. F. & Mallet, J. Complete coding sequence of rat tyrosine hydroxylase mRNA. Proc. Natl. Acad. Sci. USA 82, 617-621 (1985).